Leatt Corp LEAT
We take great care to ensure that the data presented and summarized in this overview for Leatt Corp is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in LEAT
Top Purchases
Top Sells
About LEAT
Leatt Corporation designs, develops, markets, and distributes personal protective equipment for participants of motor sports and leisure activities worldwide. The company offers Leatt-Brace system, an injection molded neck protection system designed to prevent injuries to the cervical spine and neck. It also provides helmets for head and brain protection; and body armor range, including chest protectors, full upper body protectors, upper body protection vests, back protectors, knee braces, knee and elbow guards, impact shorts and cooling vests, off-road motorcycle boots, and mountain biking shoes. In addition, the company offers other products, parts, and accessories, such as goggles; toolbelt, duffel, gear, helmet, and hydration bags; casual clothing and caps; hats; and apparels that comprises jackets, jerseys, pants, shorts, socks, and gloves, as well as aftermarket support products. Further, it acts as the original equipment manufacturer for neck braces sold by other brands. The company's products are used by riders of motorcycles, bicycles, snowmobiles, and ATVs, as well as motor racing cars and other helmeted sports. It sells its products to customers through a network of distributors and retailers; and through its online store at leatt.com. The company was formerly known as Treadzone, Inc. and changed its name to Leatt Corporation in May 2005. The company was founded in 2001 and is headquartered in Durbanville, South Africa.
Insider Transactions at LEAT
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 22
2023
|
Christopher James Leatt Director |
BUY
Grant, award, or other acquisition
|
Indirect |
51,000
+2.61%
|
$459,000
$9.35 P/Share
|
Dec 22
2023
|
Sean Macdonald Director |
BUY
Grant, award, or other acquisition
|
Direct |
76,000
+17.28%
|
$684,000
$9.35 P/Share
|
Dec 22
2023
|
Jeffrey J Guzy Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,000
+1.73%
|
$9,000
$9.35 P/Share
|
Dec 20
2022
|
Christopher James Leatt Director |
BUY
Grant, award, or other acquisition
|
Indirect |
6,800
+0.37%
|
$122,400
$18.51 P/Share
|
Dec 20
2022
|
Sean Macdonald Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+3.36%
|
$180,000
$18.51 P/Share
|
Dec 20
2022
|
Jeffrey J Guzy Director |
BUY
Grant, award, or other acquisition
|
Direct |
800
+1.42%
|
$14,400
$18.51 P/Share
|
Dec 13
2022
|
Sean Macdonald Director |
BUY
Payment of exercise price or tax liability
|
Direct |
89,270
+14.37%
|
$89,270
$1.95 P/Share
|
Jul 20
2022
|
Sean Macdonald Director |
SELL
Open market or private sale
|
Direct |
10,000
-5.04%
|
$270,000
$27.0 P/Share
|
Jul 20
2022
|
Christopher James Leatt Director |
SELL
Open market or private sale
|
Indirect |
120,000
-6.08%
|
$3,240,000
$27.0 P/Share
|
May 20
2022
|
Christopher James Leatt Director |
SELL
Open market or private sale
|
Indirect |
1,000
-0.03%
|
$24,000
$24.0 P/Share
|
May 19
2022
|
Christopher James Leatt Director |
SELL
Open market or private sale
|
Indirect |
2,000
-0.05%
|
$48,000
$24.9 P/Share
|
May 18
2022
|
Christopher James Leatt Director |
SELL
Open market or private sale
|
Indirect |
1,000
-0.03%
|
$25,000
$25.84 P/Share
|
May 17
2022
|
Christopher James Leatt Director |
SELL
Open market or private sale
|
Indirect |
1,000
-0.03%
|
$27,000
$27.5 P/Share
|
May 16
2022
|
Christopher James Leatt Director |
SELL
Open market or private sale
|
Indirect |
1,000
-0.03%
|
$26,000
$26.88 P/Share
|
May 13
2022
|
Christopher James Leatt Director |
SELL
Open market or private sale
|
Indirect |
2,000
-0.05%
|
$50,000
$25.4 P/Share
|
May 12
2022
|
Christopher James Leatt Director |
SELL
Open market or private sale
|
Indirect |
2,000
-0.05%
|
$48,000
$24.68 P/Share
|
May 11
2022
|
Christopher James Leatt Director |
SELL
Open market or private sale
|
Indirect |
1,000
-0.03%
|
$21,000
$21.5 P/Share
|
May 10
2022
|
Christopher James Leatt Director |
SELL
Open market or private sale
|
Indirect |
1,000
-0.03%
|
$22,000
$22.1 P/Share
|
May 09
2022
|
Christopher James Leatt Director |
SELL
Open market or private sale
|
Indirect |
2,000
-0.03%
|
$42,000
$21.63 P/Share
|
May 06
2022
|
Christopher James Leatt Director |
SELL
Open market or private sale
|
Indirect |
1,000
-0.03%
|
$21,000
$21.82 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 128K shares |
---|